Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...

Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...

Please provide your email address to receive an email when new articles are posted on . Over 80% of people at high risk for lung cancer were unaware of screening or had not discussed it with a doctor.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...

Here are 12 recent statistics on colorectal cancer screening rates. 68.9 colonoscopies per 1 million patients: The decrease in colorectal cancer screening rates per month for insured patients during ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it has provided genomic newborn screenings (gNBS) for ...